Stocks
Valeant Pharmaceuticals International, Inc.VRX
YHDHealthcarePharmaceuticals
A specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic drugs across areas such as dermatology, gastroenterology, and eye health through its Bausch + Lomb division. The business historically relied on acquisitions to expand its portfolio and global ...
Congressional Interest in Valeant Pharmaceuticals International, Inc. (VRX)
6 members of Congress have disclosed 23 trades in Valeant Pharmaceuticals International, Inc. (VRX), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 10 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
23
Unique Politicians
6
Buys
13
Sells
10
Who in Congress Is Trading VRX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-10-08 | David E. Price | sell | $1K – $15K |